Literature DB >> 27075454

Can the Treatment of Hypertension in the Middle-Aged Prevent Dementia in the Elderly?

Antonio Coca1, Eila Monteagudo2, Mónica Doménech2, Miguel Camafort2, Cristina Sierra2.   

Abstract

Hypertension, one of the main risk factors for cardiovascular disease, is thought to play a crucial role in the pathophysiology of cognitive impairment. Studies have associated hypertension with subjective cognitive failures and objective cognitive decline. Subjective cognitive failures may reflect the early phase of a long pathological process leading to cognitive decline and dementia that has been associated with hypertension and other cardiovascular risk factors. The underlying cerebral structural change associated with cognitive decline may be a consequence of the cerebral small-vessel disease induced by high blood pressure and may be detected on magnetic resonance imaging as white matter hyperintensities, cerebral microbleeds, lacunar infarcts or enlarged perivascular spaces. The increasing interest in the relationship between hypertension and cognitive decline is based on the fact that blood pressure control in middle-aged subjects may delay or stop the progression of cognitive decline and reduce the risk of dementia in the elderly. Although more evidence is required, several studies on hypertension have shown a beneficial effect on the incidence of dementia.

Entities:  

Keywords:  Cognitive impairment; Dementia; Hypertension; Silent brain damage

Mesh:

Substances:

Year:  2016        PMID: 27075454     DOI: 10.1007/s40292-016-0144-5

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN: 1120-9879


  45 in total

1.  Subcortical lacunes are associated with executive dysfunction in cognitively normal elderly.

Authors:  Catherine L Carey; Joel H Kramer; S Andrew Josephson; Dan Mungas; Bruce R Reed; Norbert Schuff; Michael W Weiner; Helena C Chui
Journal:  Stroke       Date:  2007-12-20       Impact factor: 7.914

2.  Cognitive complaints correlate with depression rather than concurrent objective cognitive impairment in the successful aging evaluation baseline sample.

Authors:  Zvinka Z Zlatar; Raeanne C Moore; Barton W Palmer; Wesley K Thompson; Dilip V Jeste
Journal:  J Geriatr Psychiatry Neurol       Date:  2014-03-10       Impact factor: 2.680

3.  The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study.

Authors:  Françoise Forette; Marie-Laure Seux; Jan A Staessen; Lutgarde Thijs; Marija-Ruta Babarskiene; Speranta Babeanu; Alfredo Bossini; Robert Fagard; Blas Gil-Extremera; Tovio Laks; Zhanna Kobalava; Cinzia Sarti; Jaakko Tuomilehto; Hannu Vanhanen; John Webster; Yair Yodfat; Willem H Birkenhäger
Journal:  Arch Intern Med       Date:  2002-10-14

4.  Enlarged perivascular spaces are associated with cognitive function in healthy elderly men.

Authors:  A M J Maclullich; J M Wardlaw; K J Ferguson; J M Starr; J R Seckl; I J Deary
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-11       Impact factor: 10.154

5.  Hypertension and mild cognitive impairment.

Authors:  Cristina Sierra; Mónica Doménech; Miguel Camafort; Antonio Coca
Journal:  Curr Hypertens Rep       Date:  2012-12       Impact factor: 5.369

6.  Sahlgrenska Academy Self-reported Cognitive Impairment Questionnaire (SASCI-Q)--a research tool discriminating between subjectively cognitively impaired patients and healthy controls.

Authors:  Marie Eckerström; Johanna Skoogh; Sindre Rolstad; Mattias Göthlin; Gunnar Steineck; Boo Johansson; Anders Wallin
Journal:  Int Psychogeriatr       Date:  2012-12-04       Impact factor: 3.878

7.  Cognitive impairment is related to increased arterial stiffness and microvascular damage in patients with never-treated essential hypertension.

Authors:  Helen Triantafyllidi; Chrysa Arvaniti; John Lekakis; Ignatios Ikonomidis; Nikolaos Siafakas; Stavros Tzortzis; Paraskevi Trivilou; Loukia Zerva; Eleftherios Stamboulis; Dimitrios Th Kremastinos
Journal:  Am J Hypertens       Date:  2009-03-05       Impact factor: 2.689

8.  Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study.

Authors:  Sevil Yasar; Jin Xia; Wenliang Yao; Curt D Furberg; Qian-Li Xue; Carla I Mercado; Annette L Fitzpatrick; Linda P Fried; Claudia H Kawas; Kaycee M Sink; Jeff D Williamson; Steven T DeKosky; Michelle C Carlson
Journal:  Neurology       Date:  2013-08-02       Impact factor: 9.910

9.  Achievement of cardiometabolic goals in aware hypertensive patients in Spain: a nationwide population-based study.

Authors:  José R Banegas; Auxiliadora Graciani; Juan J de la Cruz-Troca; Luz M León-Muñoz; Pilar Guallar-Castillón; Antonio Coca; Luis M Ruilope; Fernando Rodríguez-Artalejo
Journal:  Hypertension       Date:  2012-09-04       Impact factor: 10.190

Review 10.  Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies.

Authors:  Daniele Tomassoni; Alessia Lanari; Giorgio Silvestrelli; Enea Traini; Francesco Amenta
Journal:  Clin Exp Hypertens       Date:  2008-11       Impact factor: 1.749

View more
  5 in total

Review 1.  Management of Hypertension in the Elderly and Frail Elderly.

Authors:  Claudio Ferri; Livia Ferri; Giovambattista Desideri
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-02-08

2.  In Vivo Brain Plaque and Tangle Burden Mediates the Association Between Diastolic Blood Pressure and Cognitive Functioning in Nondemented Adults.

Authors:  Florence F Roussotte; Prabha Siddarth; David A Merrill; Katherine L Narr; Linda M Ercoli; Jacqueline Martinez; Natacha D Emerson; Jorge R Barrio; Gary W Small
Journal:  Am J Geriatr Psychiatry       Date:  2017-09-15       Impact factor: 4.105

3.  Neuroimaging Signatures of Cerebral Small Vessel Disease at Blood Pressure Cutoff Levels of 130/80 and 140/90 mmHg: A Population-Based Study in Community-Dwellers Aged ≥ 60 Years.

Authors:  Oscar H Del Brutto; Robertino M Mera
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-02-23

Review 4.  Hypertension and cognitive dysfunction in elderly: blood pressure management for this global burden.

Authors:  Marijana Tadic; Cesare Cuspidi; Dagmara Hering
Journal:  BMC Cardiovasc Disord       Date:  2016-11-03       Impact factor: 2.298

5.  Treating psychiatric symptoms and disorders with non-psychotropic medications
.

Authors:  Vincent Hede; Cédric Devillé
Journal:  Dialogues Clin Neurosci       Date:  2019       Impact factor: 5.986

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.